KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Dividends payables (2016 - 2025)

Historic Dividends payables for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $2.0 billion.

  • Merck's Dividends payables rose 302.72% to $2.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 billion, marking a year-over-year increase of 302.72%. This contributed to the annual value of $2.1 billion for FY2024, which is 498.74% up from last year.
  • Per Merck's latest filing, its Dividends payables stood at $2.0 billion for Q3 2025, which was up 302.72% from $2.1 billion recorded in Q2 2025.
  • In the past 5 years, Merck's Dividends payables registered a high of $2.1 billion during Q4 2024, and its lowest value of $1.7 billion during Q3 2021.
  • Moreover, its 5-year median value for Dividends payables was $1.9 billion (2022), whereas its average is $1.9 billion.
  • Its Dividends payables has fluctuated over the past 5 years, first surged by 767.93% in 2023, then soared by 302.72% in 2025.
  • Merck's Dividends payables (Quarter) stood at $1.8 billion in 2021, then grew by 6.56% to $1.9 billion in 2022, then grew by 5.36% to $2.0 billion in 2023, then grew by 4.99% to $2.1 billion in 2024, then dropped by 2.02% to $2.0 billion in 2025.
  • Its Dividends payables stands at $2.0 billion for Q3 2025, versus $2.1 billion for Q2 2025 and $2.1 billion for Q1 2025.